The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids.

@article{Maurizi2019TheRO,
  title={The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids.},
  author={Angela Maurizi and Francesco de Luca and Antonino Zangh{\`i} and Emy Manzi and Costantino Leonardo and Michele Guidotti and F Antonaccio and Valerio Olivieri and Carlo De Dominicis},
  journal={Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica},
  year={2019},
  volume={90 4},
  pages={
          260-264
        }
}
  • A. Maurizi, F. de Luca, +6 authors C. De Dominicis
  • Published 2019
  • Medicine
  • Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
INTRODUCTION Chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS) represents a challenge for the urologist, since the therapeutic efficacy does not always result in a satisfactory quality of life for the patients. Often the side effects of the medications used (antiinflammatories, antibiotics, alpha blockers) far outweighs the benefits gained with their admission. The choice of nutraceutical medications is preferred for their effectiveness, that has been accepted and proven by the… Expand
3 Citations
Diagnostic and Management Strategies for Patients with Chronic Prostatitis and Chronic Pelvic Pain Syndrome
TLDR
The pathophysiology, diagnostic work-up, and treatment of patients with CP/CPPS incorporating the most recent literature is described, including both pharmacologic and non-pharmacologic therapies. Expand
Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.
TLDR
A comprehensive search of databases using CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, trial registries, grey literature and conference proceedings found 99 unique studies in 9119 men with CP/CPPS, with assessments of 16 types of pharmacological interventions. Expand
Therapeutic effects of Qianlie Tongli decoction on chronic prostatitis/chronic pelvic pain syndrome induced by peptide T2 in mice
This study was undertaken to reveal therapeutic effects and the preliminary mechanism of Chinese medicine formula Qianlie Tongli decoction (QTD) in chronic prostatitis/chronic pelvic pain syndromeExpand

References

SHOWING 1-10 OF 22 REFERENCES
Effects of Pollen Extract in Association with Vitamins (Deprox 500®) for Pain Relief in Patients Affected by Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Results from a Pilot Study
TLDR
The pollen extract associated with vitamins (DEPROX 500®) significantly improved total symptoms, pain, and QoL in patients with non-inflammatory CP/CPPS without severe side effects in this pilot study. Expand
A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
TLDR
Compared to placebo, the pollen extract significantly improved total symptoms, pain, and QoL in patients with inflammatory CP/CPPS without severe side-effects. Expand
Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia.
TLDR
The pollen extract, Cernilton N, in a dose of 1 tablet tid for 6 months for the treatment of chronic prostatitis syndrome was well tolerated by 97% of patients and Complicating factors should be considered in patients who fail to respond to treatment within 3 months. Expand
Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial.
TLDR
Therapy with the bioflavonoid quercetin is well tolerated and provides significant symptomatic improvement in most men with chronic pelvic pain syndrome. Expand
Treatment of chronic prostatitis/chronic pelvic pain syndrome.
  • J. Nickel
  • Medicine
  • International journal of antimicrobial agents
  • 2008
TLDR
Evidence-based suggestions for treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome includeAlpha-blockers, anti-inflammatory therapy, finasteride and pentosan polysulfate are not recommended as primary treatment; however, they may have a useful adjunctive role in a multimodal therapeutic regimen. Expand
Alternative therapies in the management of chronic prostatitis/chronic pelvic pain syndrome
TLDR
CP/CPPS often requires a multimodal approach and alternative therapies should be considered as adjuncts in the treatment of refractory CP/ CPPS patients. Expand
Quercetin for chronic prostatitis/chronic pelvic pain syndrome.
TLDR
The current understanding of CP/CPPS and how treatment with quercetin can be used alone or as part of multimodal therapy are discussed. Expand
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.
TLDR
The issues considered in the design of this clinical trial may provide guidelines for future clinical trials in chronic prostatitis/chronic pelvic pain syndrome. Expand
Vitamin status of inpatients with chronic cephalgia and dysfunction pain syndrome and effects of a vitamin supplementation.
  • R. Maeder, H. Deutsch, +4 authors W. Kübler
  • Medicine
  • International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition
  • 1988
TLDR
A clear reduction in pain was more frequently observed in the active-treatment group, and a deterioration of pain more frequently in the placebo group, as well as gaps in the coverage of the vitamin supply, particularly with regard to the vitamins thiamin, riboflavin and folic acid. Expand
Therapy for prostatitis, with emphasis on bacterial prostatitis
TLDR
In chronic bacterial prostatitis, and if infection is strongly suspected in CPPS, a fluoroquinolone should be administered initially for 2 weeks, if antibiotics are strongly suspected, if pre-treatment cultures are positive and the patient has reported positive effects from the treatment. Expand
...
1
2
3
...